To include your compound in the COVID-19 Resource Center, submit it here.

ESBATech, Micromet AG deal

Micromet granted ESBATech a non-exclusive worldwide license to combined single-chain antibody (SCA) patents,

Read the full 130 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE